Chlorthalidone versus hydrochlorothiazide: A tale of tortoises and a hare

Hypertension

Volumn 58, Issue 6, 2011, Pages 994-995

  Kaplan, Norman M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORTALIDONE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; RESERPINE; VERAPAMIL;

AMBULATORY MONITORING; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG COST; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MORTALITY; NATIONAL HEALTH ORGANIZATION; NOTE; PHYSICIAN; PRIORITY JOURNAL; STROKE; TREATMENT RESPONSE;

ANTIHYPERTENSIVE AGENTS; CHLORTHALIDONE; DIURETICS; ELECTROCARDIOGRAPHY; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE;

EID: 83155180325     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.183525     Document Type: Note

References (20)

1. Ernst ME, Lund BC. Renewed interest in chlorthalidone: evidence from the Veterans Health Administration. J Clin Hypertens. 2010;12:927-934.
2. Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011;58:1008-1013.
3. Bowlus WE, Langford HG. A comparison of the antihypertensive effect of chlorthalidone and hydrochlorothiazide. Clin Pharmacol Ther. 1964;5:708-711.
4. Cranston WI, Juel-Jensen BE, Semmence AM, Handfield Jones RPC, Forbes JA, Mutch LMM. Effects of oral diuretics on raised arterial pressure. Lancet. 1963;2:966-970.
5. Multiple Risk Factor Intervention Trial Research Group. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation. 1990;82:1616-1628.
6. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
7. Rosei EA, dal Palu C, Leonetti G, Magnani B, Pessina A, Zanchetti A, for the VHAS investigators. Clinical results of the Verapamil in Hypertension and Atherosclerosis Study. J Hypertens. 1997;15:1337-1344.
8. ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypetensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
9. Kaplan NM. The choice of thiazide diuretics: why chlorthalidone may replace hydrochlorothiazide. Hypertension. 2009;54:951-953.
10. Veterans Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA. 1967;202:1028-1034.
11. Veterans Cooperative Study Group on Antihypertensive Agents. Effects on morbidity of treatment in hypertension: II-results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:1143-1152.
12. Jackson EK. Diuretics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006:737-770.
13. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlothalidone: Evidence supporting their interchangeability. Hypertension. 2004;43:4-9.
14. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman MB, Bergus GR. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47:352-358.
15. Ernst ME, Carter BL, Zheng S, Grimm RH Jr. Meta-analysis of doseresponse characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens. 2010;23:440-446.
16. Messerli FH, Makani H, Benjo A, Romero J, Alviar C, Bangalore S. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring. Am J Cardiol. 2011;57:590-600.
17. Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. 2011;57:689-694.
18. Ernst ME, Neaton JD, Grimm RH Jr, Collins G, Thomas W, Soliman EZ, Prineas RJ, for the Multiple Risk Factor Intervention Trial Research Group. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the Multiple Risk Factor Intervention Trial. Hypertension. 2011;58:1001-1007.
19. Bakris G, White WB, Weber MA, Sica D, Perez A, Cao C, Kupfer S. Results of a double-blind randomized study comparing chlorthalidone and hydrochlorothiazide combined with the new angiotensin receptor blocker azilsartan medoxomil in primary hypertension [abstract]. J Clin Hypertens. 2010;12:530.
20. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B, on behalf of the Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ. 2011;343: d4891-d4898.